• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume10, Issue4

Estimation of Oct 4 in Malignant Oral Diseases: An Original Research

    Dr Bygani Supraja Kumari, Dr Kanithi Saujanya, Dr Mamidi Deepika, Dr. Shaik. Asma sultana, Padmavathi Pyla

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 4, Pages 1302-1306

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Evaluation of OCT 4 expression in oral squamous cell carcinoma is the goal.
Materials and methods: The study contained 30 samples of archival tissue blocks, which were then divided into 10 each for the Well-differentiated & Moderately differentiated squamous cell carcinoma in the Cases (Oral squamous cell cancer) groups and 10 blocks for the control normal mucosa. Anti-Oct-4 antibody was used for immunohistochemical staining on the sections of Group I and Group II. The cells were counted, and the data were compared for significance with a p-value of 0.05 being considered significant.
Results: When the mean number of positive cells is compared between the control and study groups, statistical significance is seen on the correlation of OCT 4 expressions. When the average number of positive cells in normal mucosa and moderately differentiated Squamous cell carcinoma are compared, a strong statistical significance is seen on the association of OCT 4 expressions.
Conclusion: It appears that OCT 4 is involved in determining the prognosis of oral squamous cell carcinoma patients since its quantitative expression rose from normal mucosa to the well-differentiated variation of the disease, and then to the moderately differentiated variant
Keywords:
    Immuno-Markers OCT 4 Oral Squamous Cell Carcinoma Prognostic Markers
  • PDF (311 K)
  • XML
(2023). Estimation of Oct 4 in Malignant Oral Diseases: An Original Research. European Journal of Molecular & Clinical Medicine, 10(4), 1302-1306.
Dr Bygani Supraja Kumari, Dr Kanithi Saujanya, Dr Mamidi Deepika, Dr. Shaik. Asma sultana, Padmavathi Pyla. "Estimation of Oct 4 in Malignant Oral Diseases: An Original Research". European Journal of Molecular & Clinical Medicine, 10, 4, 2023, 1302-1306.
(2023). 'Estimation of Oct 4 in Malignant Oral Diseases: An Original Research', European Journal of Molecular & Clinical Medicine, 10(4), pp. 1302-1306.
Estimation of Oct 4 in Malignant Oral Diseases: An Original Research. European Journal of Molecular & Clinical Medicine, 2023; 10(4): 1302-1306.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 10
  • PDF Download: 9
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus